Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Depreciation & Amortization - Total (2021)

Historic Depreciation & Amortization - Total for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to $763145.0.

  • ProQR Therapeutics' Depreciation & Amortization - Total rose 2085.17% to $763145.0 in Q4 2022 from the same period last year, while for Sep 2023 it was $763145.0, marking a year-over-year decrease of 6970.32%. This contributed to the annual value of $3.0 million for FY2024, which is 993.17% up from last year.
  • Per ProQR Therapeutics' latest filing, its Depreciation & Amortization - Total stood at $763145.0 for Q4 2022, which was up 2085.17% from $617063.9 recorded in Q3 2022.
  • In the past 5 years, ProQR Therapeutics' Depreciation & Amortization - Total ranged from a high of $763145.0 in Q4 2022 and a low of $617063.9 during Q3 2022